- Home
- CSCI
as 10-04-2024 4:00pm EST
Stocks
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
| Founded: | 1990 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 12.5M | IPO Year: | 1996 |
| Target Price: | N/A | AVG Volume (30 days): | 5.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -13.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.49 - $11.10 | Next Earning Date: | 11-07-2024 |
| Revenue: | $4,915,000 | Revenue Growth: | -43.63% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest COSCIENS BIOPHARMA INC News
CSCI Breaking Stock News: Dive into CSCI Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director
GlobeNewswire
13 days ago
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
GlobeNewswire
a month ago
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
GlobeNewswire
2 months ago
COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
Compare CSCI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CSCI COSCIENS BIOPHARMA INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.